Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Psychopharmacology Bulletin|January 1, 1995
The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental healthA M PleilInternational Journal of Health Services : Planning, Administration, Evaluation|January 1, 1988
Commercial drug compendium information: a First World/Third World comparisonA M Pleil, D S PathakJournal of Thrombosis and Haemostasis : JTH|July 23, 2003
Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacementO E Dahl, A M PleilPharmacy Practice Management Quarterly|December 8, 1997
Incorporating individualized quality of life measures in the evaluation of pharmacy services: the IN*COMPASS frameworkF R Funderburk, D S Pathak, A M PleilClinical Therapeutics|July 1, 1995
Two approaches to comparing hospital charges between cadaveric renal transplant patients who received orthoclone OKT 3 sterile solution or Atgam sterile solution for induction therapyJ C Schommer, A M Pleil, D S PathakThe American Journal of Psychiatry|October 27, 1997
False positive results: a challenge for psychiatric screening in primary careA C Leon, L Portera, M Olfson, et al.Pharmacoeconomics|July 24, 2001
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDST A Lee, S D Sullivan, D L Veenstra, et al.Pharmacotherapy|March 21, 2001
Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trialZ Li, R J Willke, L A Pinto, et al.Pageof 1